Ibrutinib for Chronic Lymphocytic Leukemia

被引：0
|
作者：
Sharman, Jeff P. [1 ]
Mato, Anthony R. [2 ]
Keating, Michael J. [3 ]
机构：
[1] Willamette Valley Canc Inst & Res Ctr, Eugene, OR USA
[2] Univ Penn, Philadelphia, PA 19104 USA
[3] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2016年 / 374卷 / 16期
关键词：
PREVIOUSLY UNTREATED PATIENTS; CHLORAMBUCIL; THERAPY;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1592 / 1593
页数：2
相关论文
共 50 条
  • [1] Ibrutinib for treatment of chronic lymphocytic leukemia
    Vela, Cory M.
    McBride, Ali
    Jaglowski, Samantha M.
    Andritsos, Leslie A.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2016, 73 (06) : 367 - 375
  • [2] Ibrutinib for the treatment of chronic lymphocytic leukemia
    Deodato, Marina
    Frustaci, Anna Maria
    Zamprogna, Giulia
    Cairoli, Roberto
    Montillo, Marco
    Tedeschi, Alessandra
    EXPERT REVIEW OF HEMATOLOGY, 2019, 12 (05) : 273 - 284
  • [3] Ibrutinib in Relapsed Chronic Lymphocytic Leukemia
    Neffendorf, James E.
    Gout, Irina
    Hildebrand, G. Darius
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (13): : 1277 - 1277
  • [4] Ibrutinib (Imbruvica) for Chronic Lymphocytic Leukemia
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2014, 56 (1440): : 29 - 30
  • [5] Ibrutinib for Chronic Lymphocytic Leukemia REPLY
    Burger, Jan A.
    Styles, Lori
    Kipps, Thomas J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (16): : 1594 - 1595
  • [6] Ibrutinib Resistance in Chronic Lymphocytic Leukemia
    Furman, Richard R.
    Cheng, Shuhua
    Lu, Pin
    Setty, Menu
    Perez, Alexendar R.
    Guo, Ailin
    Racchumi, Joelle
    Xu, Guozhou
    Wu, Hao
    Ma, Jiao
    Steggerda, Susanne M.
    Coleman, Morton
    Leslie, Christina
    Wang, Y. Lynn
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (24): : 2352 - 2354
  • [7] Ibrutinib for the treatment of chronic lymphocytic leukemia
    Farooqui, Mohammed Z. H.
    Wiestner, Adrian
    EXPERT OPINION ON ORPHAN DRUGS, 2013, 1 (11): : 925 - 933
  • [8] The Use of Ibrutinib in Chronic Lymphocytic Leukemia
    Damon, Lloyd E.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2016, 14 (03) : 154 - 156
  • [9] Ibrutinib in Treatment of Patients with chronic lymphocytic Leukemia
    Flammiger, A.
    ONKOLOGE, 2015, 21 (08): : 732 - 733
  • [10] Ibrutinib in Relapsed Chronic Lymphocytic Leukemia REPLY
    Byrd, John C.
    O'Brien, Susan
    James, Danelle F.
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (13): : 1278 - 1279
12345